-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Traditional Chinese medicine formula granules are a subdivision of the traditional Chinese medicine market.
They are produced under the guidance of traditional Chinese medicine theory and combined with new technologies of modern preparations
.
At present, the formulated granule market is considered to be ushering in a new round of expansion
.
Due to the advantages of convenience in taking, the market size of traditional Chinese medicine formula granules has increased year by year, from 2 billion yuan in 2010 to 15 billion yuan in 2018, with a compound growth rate of 28.
64%.
The market size in the next five years will maintain rapid growth
.
At the same time, favorable policies are being promoted to accelerate the expansion of the industry
.
In terms of policies, since September 2017, all public hospitals have canceled the addition of medicines (except for Chinese herbal medicine pieces), which has led to an increase in the use of Chinese medicine pieces, including Chinese medicine formula granules, and promoted the expansion of the market size of Chinese medicine formula granules
.
On February 10, 2021, the "Announcement on Ending the Pilot Work of TCM Formula Granules" was released, which means that TCM formula granules will be fully liberalized after more than 20 years of pilot work, and enterprises will have "national standards" for production, which will benefit the further development of TCM formula granules
.
At the same time, with the expansion of hospital and medical insurance coverage, the industry is expected to continue to grow at a high rate
.
In addition, the pace of normalization and standardization is also accelerating
.
In November 2019, the National Pharmacopoeia Committee issued the "Announcement on the Unified Standards for the Pilot Variety of Formula Granules".
The implementation of this policy will improve the quality standard construction of traditional Chinese medicine formula granules and standardize the development of the industry.
"Technical Requirements for Control and Standard Formulation" was released to realize the overall quality control and effective supervision of formula granules, and the pace of industry standardization and standardization was accelerated
.
According to statistics, 200 national standards for formula granules have been released, and dozens of national quality standards for formula granules are being announced, and provincial standards for formula granules are also advancing.
At present, 11 provinces have issued 200 or more.
Provincial formula particle standard
.
With the acceleration of unified standard work and inter-provincial joint procurement, and the continuous release of policy dividends, the market space of traditional Chinese medicine formula granules is widely optimistic
.
Many institutions predict that by 2030, the market size of traditional Chinese medicine granules will reach 100 billion yuan
.
It is worth mentioning that there are both opportunities and challenges
.
At present, a major challenge facing traditional Chinese medicine formula granules is the approaching centralized procurement
.
As early as August 2021, when the National Medical Insurance Administration responded to the "Suggestions on Accelerating the Entry of Chinese Medicines and Formula Granules into Centralized Procurement", it stated that it would accelerate the inclusion of Chinese patent medicines and formula granules in centralized procurement
.
In March 2022, the Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Notice on Announcement of the Dynamic Adjustment of Online Purchasing Information for Some TCM Decoction Pieces and TCM Formula Granules", followed by Hunan, Inner Mongolia, Shandong, Fujian, Hainan and other provinces.
Notice on the purchase of formula granules on the net
.
The industry believes that from the experience of centralized procurement of other drugs, the policy will have some impact on pharmaceutical companies
.
With the implementation of online procurement in various provinces, traditional Chinese medicine formula granules may also face squeezed price water, so the enterprises that deploy need to make certain preparations
.
The above-mentioned people believe that the hospital is the main channel for the sales of traditional Chinese medicine granules, so the opening of medical insurance payment is very critical to its future development
.
"After the Chinese medicine formula granules enter the medical insurance, it can have a positive impact on the enterprise itself, and at the same time, it is conducive to promoting the modernization and high-quality development of the Chinese medicine industry.
As more and more pharmaceutical companies enter the medical insurance, the competition will be more intense.
.
"Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
They are produced under the guidance of traditional Chinese medicine theory and combined with new technologies of modern preparations
.
At present, the formulated granule market is considered to be ushering in a new round of expansion
.
Due to the advantages of convenience in taking, the market size of traditional Chinese medicine formula granules has increased year by year, from 2 billion yuan in 2010 to 15 billion yuan in 2018, with a compound growth rate of 28.
64%.
The market size in the next five years will maintain rapid growth
.
At the same time, favorable policies are being promoted to accelerate the expansion of the industry
.
In terms of policies, since September 2017, all public hospitals have canceled the addition of medicines (except for Chinese herbal medicine pieces), which has led to an increase in the use of Chinese medicine pieces, including Chinese medicine formula granules, and promoted the expansion of the market size of Chinese medicine formula granules
.
On February 10, 2021, the "Announcement on Ending the Pilot Work of TCM Formula Granules" was released, which means that TCM formula granules will be fully liberalized after more than 20 years of pilot work, and enterprises will have "national standards" for production, which will benefit the further development of TCM formula granules
.
At the same time, with the expansion of hospital and medical insurance coverage, the industry is expected to continue to grow at a high rate
.
In addition, the pace of normalization and standardization is also accelerating
.
In November 2019, the National Pharmacopoeia Committee issued the "Announcement on the Unified Standards for the Pilot Variety of Formula Granules".
The implementation of this policy will improve the quality standard construction of traditional Chinese medicine formula granules and standardize the development of the industry.
"Technical Requirements for Control and Standard Formulation" was released to realize the overall quality control and effective supervision of formula granules, and the pace of industry standardization and standardization was accelerated
.
According to statistics, 200 national standards for formula granules have been released, and dozens of national quality standards for formula granules are being announced, and provincial standards for formula granules are also advancing.
At present, 11 provinces have issued 200 or more.
Provincial formula particle standard
.
With the acceleration of unified standard work and inter-provincial joint procurement, and the continuous release of policy dividends, the market space of traditional Chinese medicine formula granules is widely optimistic
.
Many institutions predict that by 2030, the market size of traditional Chinese medicine granules will reach 100 billion yuan
.
It is worth mentioning that there are both opportunities and challenges
.
At present, a major challenge facing traditional Chinese medicine formula granules is the approaching centralized procurement
.
As early as August 2021, when the National Medical Insurance Administration responded to the "Suggestions on Accelerating the Entry of Chinese Medicines and Formula Granules into Centralized Procurement", it stated that it would accelerate the inclusion of Chinese patent medicines and formula granules in centralized procurement
.
In March 2022, the Shanghai Sunshine Pharmaceutical Purchasing Network issued the "Notice on Announcement of the Dynamic Adjustment of Online Purchasing Information for Some TCM Decoction Pieces and TCM Formula Granules", followed by Hunan, Inner Mongolia, Shandong, Fujian, Hainan and other provinces.
Notice on the purchase of formula granules on the net
.
The industry believes that from the experience of centralized procurement of other drugs, the policy will have some impact on pharmaceutical companies
.
With the implementation of online procurement in various provinces, traditional Chinese medicine formula granules may also face squeezed price water, so the enterprises that deploy need to make certain preparations
.
The above-mentioned people believe that the hospital is the main channel for the sales of traditional Chinese medicine granules, so the opening of medical insurance payment is very critical to its future development
.
"After the Chinese medicine formula granules enter the medical insurance, it can have a positive impact on the enterprise itself, and at the same time, it is conducive to promoting the modernization and high-quality development of the Chinese medicine industry.
As more and more pharmaceutical companies enter the medical insurance, the competition will be more intense.
.
"Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
